iqo receiv pmta approv us
altria today announc fda authoris iqo us via pmta applic
altria launch georgia initi scale rememb altria
previous said expect month lag post approv lead market launch
probabl expect see product sometim juli could
implic regard rate vapour growth juul bat reduc risk
rrp strategi fda rrp approv
happen
altria today announc fda authoris iqo us via pmta applic
altria launch atlanta georgia initi learn scale
nationwid plan number retail touchpoint atlanta includ
iqo store distribut around store rememb altria previous
said expect month lag post approv lead market launch
probabl expect see product sometim juli
posit develop mo pm sentiment
news posit sentiment mo pm particularli pm
come risk see cigarett busi us nonetheless
still remain cautiou name mo still believ model
challeng given control full econom either juul iqo
pm still think rate growth iqo next month includ
us could disappoint vs expect
possibl implic around vapour growth inde juul
although heat arguabl target older demograph smoker
interest see impact vapour growth follow introduct trend
think need watch close growth juul given altria
posit push heat vapour unit econom
vapour us profit altria own juul may
incentivis push iqo although also know exact econom
assum cost plu paid pm present
also put pressur bat vocal around revo
bat also heat tobacco product approv us call revo/eclips
unlik ioq use carbon tip technolog vs separ devic bat date
chosen primarili focu vapour smokeless mention
us heat recent investor day argu like littl
appetit heat tobacco us focus resourc
elsewher view would prefer vapour particularli smokeless due
attract econom bat forc make clear plan
heat product could potenti impact target mix profit
develop us
would suggest fda approv could forthcom
would suggest iqo approv fda support view see
fda approv reduc risk space soon would expect bat camel
snu get mrtp approv first also see swedish match gener snu
approv like possibl also altria copenhagen snuff
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi downsid risk discount fda vapour intervent
unfavour iqo term menthol ban upsid risk marlboro begin gain share juul growth continu
trajectori us intern expans success crono global winner cannabi
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi risk subdu rrp non-deliveri deal synergi
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi risk combust pressur rrp contribut stall
valu swedish match sum part use year dcf differ busi segment individu risk
competit pressur scandi intensifi regul significantli impact cigar volum traction stall us snus/nic pouch
owen bennett cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli
indirectli relat specif recommend view express research report
ryan tomkin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
registr non-u analyst owen bennett cfa employ jefferi intern limit non-u affili
jefferi llc registered/qualifi research analyst finra analyst may associ person
jefferi llc finra member firm therefor may subject finra rule restrict commun
subject compani public appear trade secur held research analyst
registr non-u analyst ryan tomkin employ jefferi intern limit non-u affili jefferi llc
registered/qualifi research analyst finra analyst may associ person jefferi llc
finra member firm therefor may subject finra rule restrict commun subject
compani public appear trade secur held research analyst
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom
seek updat research appropri variou regul may prevent us asid certain industri
report publish period basi larg major report publish irregular interv appropri analyst
articl articl
jefferi group llc make market secur adr british american tobacco
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within
pleas see import disclosur inform page report
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold
rate secur averag secur price consist expect total return price appreci plu yield
plu minu within period under-perform rate secur averag secur price consist
expect total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi
project opinion invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ
restrict analys market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf
averag group price-to-earnings sum part net asset valu dividend return return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month
period stock select base fundament analysi may take account factor analyst convict
differenti analysi favor risk/reward ratio invest theme jefferi analyst recommend jefferi
franchis pick includ buy rate stock number vari depend analyst recommend inclus
stock ad new opportun aris remov reason inclus chang stock met desir
return longer rate buy and/or trigger stop loss stock day volatil bottom quartil
stock continu stop loss remaind stop franchis pick intend repres
recommend portfolio stock sector base may note believ pick fall within invest
style growth valu
risk may imped achiev price target
report prepar gener circul provid invest recommend specif individu investor
financi instrument discuss report may suitabl investor investor must make
invest decis base upon specif invest object financi situat util financi advisor
deem necessari past perform financi instrument recommend report taken
indic guarante futur result price valu incom financi instrument mention
report rise well fall may affect chang econom financi polit factor financi instrument
denomin currenc investor home currenc chang exchang rate may advers affect price
valu incom deriv financi instrument describ report addit investor secur adr
whose valu affect currenc underli secur effect assum currenc risk
compani mention report
pleas see import disclosur inform page report
rate price target histori british american tobacco bat ln
rate price target histori british american tobacco bti
rate price target histori inc mo
pleas see import disclosur inform page report
